MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.

As of December 31, 2020, MGI has 1,726 employees, and 32.79% of whom are R&D personnel. Founded in 2016, MGI operates in more than 70 countries and regions, serving more than 1000 customers. It has established scientific research and production bases, global training and service network in many countries and regions around the world. MGI is one of the companies in the world that have the ability to independent develop and mass-produce clinical high-throughput gene sequencers. Providing real-time, comprehensive, life long solutions, its vision is to lead life science innovation.